Equity Capital And Reserves Lave om Dato
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Amgen USD 6.23B 1.42B 2023-12
Baxter International USD 8.4B 301M 2023-12
BioCryst Pharmaceuticals USD -410986000 22.27M 2023-09
Biogen USD 14.8B 315.6M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Cara Therapeutics USD 85.64M 23.29M 2023-09
Eisai JPY 861.67B 16.8B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Esperion Therapeutics USD -410004000 38.03M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Grifols EUR 6.13B 265.26M 2023-09
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Ironwood Pharmaceuticals USD -346295000 23.08M 2023-12
Merck USD 41.25B 2.55B 2023-09
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Takeda JPY 7.07T 149.3B 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Xencor USD 668.8M 214K 2023-12



Nektar Therapeutics Egenkapital Og Reserver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.